Philippine Health Insurance Corporation v. Galauran
NEW DOCTRINEFacts
The Antecedents: PhilHealth, a government-owned and controlled corporation (GOCC) established under Republic Act No. 7875, as amended, conducted a spot inspection and claims validation at WellMed Dialysis and Laboratory Center Corporation (WellMed). The inspection revealed that WellMed filed anomalous claims for patients who were already deceased and received out-of-pocket payments from members without issuing receipts. Specifically, WellMed filed benefit claims for patient Bebian M. Albante, who had died on July 16, 2016, for hemodialysis sessions in August and September 2016. Dr. Jose Mari Del Valle Galauran (Dr. Galauran), a PhilHealth-accredited health care professional (HCP) specializing in nephrology, was alleged to have certified that Albante underwent dialysis sessions after her death. Procedural History: A Complaint-Affidavit was filed against Dr. Galauran and WellMed, charging Dr. Galauran with misrepresentation by furnishing false or incorrect information and breach of warranties of accreditation under the Revised Implementing Rules and Regulations (RIRR) of the National Health Insurance Act (NHIA). PhilHealth issued an order withdrawing Dr. Galauran's accreditation. Dr. Galauran contested this, reiterating his defenses that Albante was not his patient, he was not a resident physician at WellMed, and he had no participation in the alleged fraudulent claims. He also claimed to be a victim of WellMed's machinations and that whistleblowers admitted forging signatures. PhilHealth's President and CEO denied his appeal. Dr. Galauran then filed a petition for certiorari before the Court of Appeals (CA), arguing that the PhilHealth Orders revoking his accreditation were not issued by the PhilHealth Board and that he was denied due process. The CA granted his petition, setting aside PhilHealth's orders, ruling that the authority to withdraw accreditation lies with the PhilHealth Board and that Dr. Galauran's right to due process was violated. PhilHealth's motion for reconsideration was denied. PhilHealth then filed a Petition for Review on Certiorari before the Supreme Court. The Petition: PhilHealth argued that its President and CEO, along with the Vice President, acted within their jurisdiction in withdrawing Dr. Galauran's accreditation, that its accreditation procedure is separate from its arbitration procedure, and that Dr. Galauran was afforded due process. The Supreme Court denied PhilHealth's application for a temporary restraining order and/or writ of preliminary injunction and proceeded to resolve the case.
Issue(s)
Whether Dr. Galauran's accreditation was revoked arbitrarily and without lawful authority by the PhilHealth President CEO and Vice President. Whether Dr. Galauran was afforded due process.
Ruling
The Supreme Court affirmed the Decision and Resolution of the Court of Appeals. It ruled that PhilHealth arbitrarily and unlawfully revoked Dr. Galauran's accreditation and did not afford him due process. Consequently, the CA did not gravely abuse its discretion in setting aside the assailed Orders of PhilHealth. ACCORDINGLY, the Petition for Review on Certiorari is DENIED. The Decision dated September 13, 2023, and the Resolution dated December 13, 2023, of the Court of Appeals in CA-G.R. SP No. 169097 are AFFIRMED.
Ratio Decidendi
On the issue of arbitrary and unlawful revocation of accreditation: The Court held that PhilHealth acted arbitrarily and unlawfully when it revoked Dr. Galauran's accreditation. While PhilHealth cited various provisions of the NHIA and its RIRR to support the authority of its President and CEO to withdraw accreditation, a plain reading of these provisions does not grant the President any quasi-judicial power of revocation or withdrawal. The RIRR, specifically Section 75, clearly vests the quasi-judicial powers, including the power to suspend temporarily or permanently revoke accreditation, in the PhilHealth Board. The Court emphasized that the basic application for accreditation is separate and distinct from the withdrawal or revocation of accreditation; while the former can be resolved by the President and CEO, only the PhilHealth Board, exercising its quasi-judicial power, can act on the latter. Therefore, the withdrawal of Dr. Galauran's accreditation by the President and CEO was without lawful authority and a patent nullity. On the issue of denial of due process: The Court agreed with the CA that Dr. Galauran was denied his constitutional right to due process. PhilHealth failed to furnish Dr. Galauran with a copy of the material document showing that he allegedly received PHP 6,650.00 for the ghost dialysis sessions of Albante. This omission violated his right to know the case he had to meet, which is a minimum standard of due process. Furthermore, PhilHealth's own documentary evidence failed to substantially establish the violations charged against Dr. Galauran. The evidence showed that the deceased patient's attending physician was Dr. Natividad, not Dr. Galauran, and that Dr. Galauran's name appearing in a computer-generated report did not prove he prepared any report for Albante. This lack of substantial evidence, coupled with the failure to provide a crucial document, constituted a violation of due process. The Court reiterated that administrative agencies' factual findings are generally accorded respect, but this is only when they are not tainted with unfairness or arbitrariness amounting to abuse of discretion or lack of jurisdiction, which was evident in this case.
Main Doctrine
The PhilHealth Board, exercising its quasi-judicial power, is vested with the sole authority to withdraw or revoke the accreditation of a health care provider. Actions taken by the PhilHealth President and CEO or Vice President in withdrawing accreditation, without the Board's proper exercise of quasi-judicial power, are arbitrary, unlawful, and null and void. Furthermore, failure to furnish a respondent with copies of material documents forming the basis of charges constitutes a violation of the constitutional right to due process.